Focal sparing (focal fat-spared area) is a focally preserved island of normal parenchyma in a diffusely steatotic (fatty) liver. It is not a true mass or neoplasm — while surrounding parenchyma shows diffuse fatty infiltration, this area maintains normal hepatocyte structure. It occurs in typical locations: segment 4 (adjacent to falciform ligament, periligamentous), gallbladder fossa (perivesicular), periportal bifurcation area, and subcapsular region. It is the exact opposite of focal steatosis: in focal steatosis fat accumulates in a normal liver, in focal sparing a normal area remains in a fatty liver. On CT it may appear denser (hyperdense) than surrounding fatty parenchyma, mimicking a mass and potentially being confused with metastasis or other solid lesions. Diagnosis can be definitively made with MRI chemical shift imaging: surrounding steatotic parenchyma loses signal on opposed-phase while the focal sparing area does not lose signal.
Age Range
20-80
Peak Age
50
Gender
Equal
Prevalence
Common
Focal sparing is the preservation of certain regions from fatty infiltration in a diffusely steatotic liver. The pathophysiological mechanism is the exact opposite of focal steatosis and is related to the dual blood supply of the liver. Typical sparing locations (adjacent to falciform ligament, gallbladder fossa) receive aberrant venous drainage — these regions receive systemic venous blood (gastric, cystic vein) rather than insulin-rich portal blood. Diffuse steatosis is generally related to insulin-mediated lipogenesis; insulin stimulates hepatocyte triglyceride synthesis. Regions receiving aberrant venous drainage are exposed to lower insulin concentration → less triglyceride synthesis → preservation from fatty infiltration. The reason this normal parenchyma appears different from the fatty surroundings on imaging is the difference in tissue composition: normal parenchyma is water-dominant, surrounding parenchyma is a water+fat mixture. On CT, the low attenuation of fat makes surrounding parenchyma hypodense → the sparing area appears relatively hyperdense. On MRI chemical shift, surrounding steatotic parenchyma shows intravoxel signal cancellation on opposed-phase (water+fat protons cancel each other), no signal cancellation occurs in the sparing area as there is no fat → the sparing area remains brighter on opposed-phase.
On chemical shift MRI opposed-phase images, the focal sparing area preserving signal while surrounding steatotic parenchyma loses signal — direct evidence of absence of intracellular fat. Combined with absence of mass effect and typical location, diagnosis is definitive.
On chemical shift MRI, the focal sparing area does not lose signal on opposed-phase images — maintains the same signal intensity as in-phase. In contrast, surrounding steatotic parenchyma shows marked signal drop on opposed-phase (intravoxel signal cancellation due to intracellular fat). This contrast difference makes the focal sparing area appear brighter than the surroundings, creating a 'pseudolesion'. The signal difference between surrounding parenchyma and sparing area is less prominent on in-phase images.
Report Sentence
On MRI chemical shift imaging, surrounding steatotic parenchyma shows marked signal drop on opposed-phase, while signal is preserved in the indicated area, consistent with focal sparing.
In a diffusely steatotic liver, the focal sparing area appears denser (hyperdense) than surrounding fatty parenchyma. While normal liver density is 55-65 HU and steatotic parenchyma drops to 30-40 HU, the focal sparing area maintains normal density values (55-65 HU). This density difference can make the focal sparing area appear like a 'mass'. Geographic irregular margins and absence of mass effect are differentiating. Enhances at the same rate as surrounding parenchyma in contrast phases.
Report Sentence
A relatively hyperdense area compared to surrounding fatty parenchyma is observed in typical location in a diffusely steatotic liver with no mass effect detected; consistent with focal sparing.
Focal hypoechoic area in a diffusely steatotic (hyperechoic) liver — darker than surrounding fatty parenchyma. This appearance can give the impression of a solid mass and may be confused with metastasis in particular. Typical location (segment 4, gallbladder fossa), geographic margins, and absence of mass effect are helpful in diagnosis. No abnormal vascularity is detected on Doppler. No posterior acoustic shadowing.
Report Sentence
Focal hypoechoic area compared to surrounding hyperechoic parenchyma is observed at typical location in a diffusely steatotic liver with no mass effect; consistent with focal sparing.
On contrast-enhanced CT in the portal venous phase, the focal sparing area and surrounding steatotic parenchyma enhance at the same rate. No enhancement difference occurs — confirming that both regions have normal vascular architecture. The density difference prominent on non-contrast CT (sparing > steatotic surroundings) may decrease or disappear in contrast phases because contrast retention is equal in both areas.
Report Sentence
In contrast phases, the focal sparing area and surrounding steatotic parenchyma show the same enhancement pattern, excluding neoplastic lesion.
Focal sparing area does not show diffusion restriction on DWI. ADC values are similar to surrounding parenchyma. This finding confirms the area is not neoplastic and differentiates from highly cellular lesions such as metastasis.
Report Sentence
No diffusion restriction is detected in the relevant area on DWI with ADC values similar to surrounding parenchyma; neoplastic process is excluded.
The focal sparing area appears isointense to surrounding parenchyma on T2-weighted images. Shows no significant T2 hyperintensity or hypointensity. This reflects that the water content of the area is similar to surrounding parenchyma and differentiates from T2-bright lesions such as hemangioma or cyst.
Report Sentence
The area shows isointense appearance to surrounding parenchyma on T2-weighted images with no finding consistent with cystic or vascular lesion.
Criteria
Adjacent to falciform ligament (segment 4) — most common location
Distinct Features
Most common form. Occurs due to direct flow of aberrant gastric venous drainage to segment 4. Typical location facilitates diagnosis — usually no additional workup needed.
Criteria
Adjacent to gallbladder fossa
Distinct Features
Related to cystic venous drainage providing systemic venous blood to this area. Proximity to gallbladder wall is helpful in diagnosis.
Criteria
In any segment outside typical locations
Distinct Features
High risk of confusion with mass lesion. MRI chemical shift is critical for diagnosis. Short-term follow-up or biopsy may be considered.
Distinguishing Feature
Metastasis causes mass effect (vessel displacement), focal sparing does not. Metastasis shows diffusion restriction on DWI (low ADC), focal sparing does not. Metastasis shows different enhancement pattern (rim/heterogeneous). MRI chemical shift definitively diagnoses focal sparing.
Distinguishing Feature
Focal steatosis is a fat-containing area in a normal liver (hypodense on CT); focal sparing is a fat-spared area in a steatotic liver (relatively hyperdense on CT). On MRI, focal steatosis loses signal on opposed-phase; focal sparing area does not lose signal but surrounding parenchyma does.
Distinguishing Feature
HCC shows mass morphology (round/oval), capsule, arterial enhancement and washout; focal sparing is geographically margined, unencapsulated, shows same enhancement as surrounding parenchyma. HCC shows diffusion restriction. HCC usually occurs in cirrhotic liver.
Distinguishing Feature
FNH shows round/oval mass morphology, hypervascular enhancement in arterial phase, central scar, and hepatobiliary phase uptake; focal sparing has geographic margins, no specific enhancement, and no mass morphology.
Urgency
routineManagement
conservativeBiopsy
Not NeededFollow-up
no-follow-upFocal sparing is a benign condition and requires no treatment. Diagnosis can be definitively made with MRI chemical shift imaging. Typical location + absence of mass effect + area consistent with opposed-phase signal loss in surrounding steatotic parenchyma confirms diagnosis. Metabolic risk factors for underlying diffuse steatosis should be evaluated. Short-term follow-up (3-6 months) may be considered for atypical location or clinical suspicion.
Focal sparing is a benign pseudolesion. No treatment or follow-up is required. It is a component of fatty liver disease. The key clinical consideration is not to confuse it with true lesions.